Dupilumab Improved Long-term Lung Function in Children Aged 6 to 11 Years With Moderate-to-Severe Asthma: Liberty Asthma Excursion

被引：0
|
作者：
Bacharier, L. B. [1 ]
Maspero, J. F. [2 ]
Katelaris, C. H. [3 ]
Fiocchi, A. G. [4 ]
Gagnon, R. [5 ]
de Mir, I. [6 ]
Guilbert, T. W. [7 ,8 ]
Jackson, D. J. [9 ]
Li, N. [10 ]
Akinlade, B. [11 ]
Laws, E. [10 ]
Mannent, L. P. [12 ]
Maloney, J. [11 ]
Tawo, K. [10 ]
Khokhar, F. A. [11 ]
Hardin, M. [13 ]
Abdulai, R. M. [13 ]
Lederer, D. J. [11 ]
Robinson, L. B. [13 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Pediat, Nashville, TN USA
[2] Fdn CIDEA, Buenos Aires, DF, Argentina
[3] Campbelltown Hosp, Campbelltown, NSW, Australia
[4] Bambino Gesu Pediat Hosp, IRCCS, Rome, Italy
[5] Clin Specialisee Allergie Capitale, Quebec City, PQ, Canada
[6] Hosp Univ Maternoinfantil Vall dHebron, Barcelona, Spain
[7] Cincinnati Childrens Hosp, Cincinnati, OH USA
[8] Univ Cincinnati, Cincinnati, OH USA
[9] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA
[10] Sanofi, Bridgewater, NJ USA
[11] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[12] Sanofi, Chilly Mazarin, France
[13] Sanofi, Cambridge, MA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5988
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Dupilumab in children with moderate-to-severe asthma: A cost utility analysis
    Buendia, Jefferson A.
    Patino, Diana G.
    PEDIATRIC PULMONOLOGY, 2022, 57 (10) : 2313 - 2319
  • [42] Dupilumab Reduces Severe Exacerbations and Improves Lung Function in Late-Onset, Uncontrolled, Moderate-to-Severe Asthma Patients Enrolled in the LIBERTY ASTHMA QUEST Study
    Hanania, N. A.
    Bateman, E. D.
    Castro, M.
    Pavord, I. D.
    Papi, A.
    FitzGerald, J. M.
    Maspero, J. F.
    Katelaris, C.
    Singh, D.
    Rice, M. S.
    Rowe, P.
    Lu, Y.
    Amin, N.
    Staudinger, H. W.
    Graham, N. M. H.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [43] Dupilumab Efficacy in LIBERTY ASTHMA QUEST Patients With Uncontrolled, Moderate-to-Severe Asthma By Allergen Sensitization Status
    Corren, Jonathan
    Jackson, David
    Casale, Thomas
    Borish, Larry
    Rabe, Klaus
    Busse, William
    Maspero, Jorge
    Jackson, Daniel
    Daizadeh, Nadia
    Ortiz, Benjamin
    Jacob-Nara, Juby
    Khodzhayev, Angela
    Rowe, Paul
    Djandji, Michel
    Deniz, Yamo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB15 - AB15
  • [44] DUPILUMAB EFFICACY IN UNCONTROLLED, MODERATE-TO-SEVERE ALLERGIC ASTHMA IN THE PHASE 3 LIBERTY ASTHMA QUEST STUDY
    Castro, M.
    Corren, J.
    Hanania, N.
    Pavord, I.
    Quirce, S.
    Thangavelu, K.
    Rice, M.
    O'Riordan, T.
    Maroni, J.
    Rowe, P.
    Lu, Y.
    Amin, N.
    Ruddy, M.
    Akinlade, B.
    Graham, N.
    Teper, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S8 - S8
  • [45] Dupilumab Effect on Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma with an Allergic Phenotype
    Castro, M.
    Corren, J.
    Casale, T. B.
    Quirce, S.
    Rice, M. S.
    Deniz, Y.
    Rowe, P.
    Amin, N.
    Teper, A.
    PNEUMOLOGIE, 2020, 74 : S89 - S89
  • [46] Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype
    Castro, Mario
    Corren, Jonathan
    Casale, Thomas B.
    Quirce, Santiago
    Rice, Megan S.
    Deniz, Yamo
    Rowe, Paul
    Amin, Nikhil
    Teper, Ariel
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [47] Lung function trajectories in a cohort of patients with moderate-to-severe asthma on mepolizumab, omalizumab, or dupilumab
    Nopsopon, Tanawin
    Barrett, Nora A.
    Phipatanakul, Wanda
    Laidlaw, Tanya M.
    Weiss, Scott T.
    Akenroye, Ayobami
    ALLERGY, 2024, 79 (05) : 1195 - 1207
  • [48] Biomarkers associated with lung function decline and dupilumab response in patients with moderate-to-severe asthma
    Pavord, I. D.
    Brusselle, G.
    Jackson, D. J.
    Brightling, C. E.
    Papi, A.
    Maspero, J. F.
    Rabe, K. F.
    Korn, S.
    Zhang, M.
    Pandit-Abid, N.
    Hardin, M.
    Gomez, L. De Prado
    Jacob-Nara, J. A.
    Rowe, P. J.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [49] Dupilumab treatment normalizes skin barrier function in children aged 6-11 years with moderate-to-severe atopic dermatitis
    Cork, Michael J.
    Leung, Donald
    Ong, Peck
    Danby, Simon
    Ramirez-Gama, Marco
    Garcia, Shannon
    Patricia, Taylor
    Byers, Rob
    Matcher, Stephen
    Zahn, Joseph
    Bologna, Gabriel
    Zhang, Annie
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : I30 - I30
  • [50] Long-Term Efficacy of Dupilumab in Quadrants of Elevated- vs Low- Type 2 Biomarker Patients With Uncontrolled, Moderate-to-Severe Asthma: LIBERTY ASTHMA TRAVERSE
    Wechsler, Michael
    Pavord, Ian
    Papi, Alberto
    Chapman, Kenneth
    Mao, Xuezhou
    Ortiz, Benjamin
    Djandji, Michel
    Jacob-Nara, Juby
    Rowe, Paul
    Deniz, Yamo
    Laws, Elizabeth
    Akinlade, Bolanle
    Amin, Nikhil
    Lederer, David
    Hardin, Megan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB190 - AB190
12345